Joachim Auerbach
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Sugar-Sweetened Beverage Tax (Sugar Tax): Innovation and Stasis.
Journal: Irish medical journal
Published: June 25, 2026
Exploring the sugar-sweetened beverage tax (SSBT) pass-through rate in the Irish hospitality sector.
Exploring the sugar-sweetened beverage tax (SSBT) pass-through rate in the Irish hospitality sector.
Journal: BMC public health
Published: April 10, 2024
Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia.
Journal: Drugs in R&D
Published: July 29, 2022
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
Journal: Infectious diseases and therapy
Published: April 18, 2022
COVID-19 vaccine development, production and regulatory oversight in African countries.
Journal: Bulletin of the World Health Organization
Published: January 29, 2022
GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
Journal: Infectious diseases and therapy
Published: November 26, 2021
The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia.
Journal: Drugs in R&D
Published: October 28, 2021
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
Journal: EClinicalMedicine
Published: May 20, 2021
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.
Journal: Frontiers in immunology
Published: January 04, 2019
Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction.
Journal: Frontiers in public health
Published: November 30, 2018
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Journal: Frontiers in immunology
Published: October 11, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026